Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuropeptide Y receptor type 1 (NPY1R) is a G protein-coupled receptor that mediates the effects of neuropeptide Y (NPY), peptide YY, and pancreatic polypeptide. It is involved in diverse physiological functions including appetite regulation, vasoconstriction, cell proliferation, and modulation of anxiety. NPY1R is a potential therapeutic target for obesity and certain cancers, especially breast cancer. Its expression pattern makes it a potential biomarker candidate for disease states involving altered neuropeptidergic signaling or tissue remodeling/inflammation.
Agonist or antagonist binding to the NPY1R receptor, leading to downstream signaling via G proteins and influencing various physiological processes.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y Receptor Type 1 (NPY1R).